ArticleBioanalysis2026

From anti-drug antibody incidence to clinical relevance: interpreting highly sensitive immunogenicity assays in biosimilars.

Anita Krishnan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.